Is there increasing evidence that the risks of rhAPC may outweigh its benefits?

被引：2
作者：
Plataki, Maria [1 ]
Vaporidi, Katerina [1 ]
Georgopoulos, Dimitris [1 ]
机构：
[1] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Intens Care Med, Iraklion, Greece
来源：
INTENSIVE CARE MEDICINE | 2007年 / 33卷 / 08期
关键词：
D O I：
10.1007/s00134-007-0707-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1485 / 1486
页数：2
相关论文
共 8 条
  • [1] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
  • [2] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [3] Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey
    Bertolini, Guido
    Rossi, Carlotta
    Anghileri, Abramo
    Livigni, Sergio
    Addis, Antonio
    Poole, Daniele
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (03) : 426 - 434
  • [4] Increasing evidence that the risks of rhAPC may outweigh its benefits
    Eichacker, Peter Q.
    Natanson, Charles
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (03) : 396 - 399
  • [5] Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study
    Kanji, Salmaan
    Perreault, Marc M.
    Chant, Clarence
    Williamson, David
    Burry, Lisa
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (03) : 517 - 523
  • [6] Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial
    Nadel, Simon
    Goldstein, Brahm
    Williams, Mark D.
    Dalton, Heidi
    Peters, Mark
    Macias, William L.
    Abd-Allah, Shamel A.
    Levy, Howard
    Angle, Robinette
    Wang, Dazhe
    Sundin, David P.
    Giroir, Brett
    [J]. LANCET, 2007, 369 (9564) : 836 - 843
  • [7] TANZI M, 2004, USE DROTRECOGIN ALFA
  • [8] Dyotyecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
    Vincent, JL
    Bernard, GR
    Beale, R
    Doig, C
    Putensen, C
    Dhainaut, JF
    Artigas, A
    Fumagalli, R
    Macias, W
    Wright, T
    Wong, K
    Sundin, DP
    Turlo, MA
    Janes, J
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (10) : 2266 - 2277
1